Indications and uses
For the temporary relief of minor back pain, leg & hip pain, muscle spasm
For the temporary relief of minor back pain, leg & hip pain, muscle spasm
At first sign of symptoms: Adults and children 12 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Standard dosage: Adults and children 12 years and older: take 1-2 tablets 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 12, consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow.
Each tablet contains: Ammonium muriaticum 6X, *Chamomilla 10X, *Colocynthis 5X, *Gelsemium sempervirens 6X, *Gnaphalium polycephalum 5X, *Rhus toxicodendron 8X 50 mg each.
*Natural Ingredients
Inactive Ingredients: **Dextrose, ** Lactose, Magnesium Stearate, **Maltodextrin
**contains one or more of these ingredients.
Back Pain Relief Tablets
Relieves:
• Back Pain
• Leg & Hip Pain
• Muscle Spasm
For the temporary relief of minor back pain, leg & hip pain, muscle spasm
At first sign of symptoms:
Adults and children 12 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage.
Standard dosage: Adults and children 12 years and older: take 1-2 tablets 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 12, consult your health professional.
Allow tablets to dissolve completely in the mouth, do not swallow.
Warnings: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Back or any of its ingredients exists.
Keep out of reach of children.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62795-1007-2 | BHI Back | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 62795-1007-3 | BHI Back | 1 in 1 CARTON | TABLET | 1 | 4 | |
| 62795-1007-3 | BHI Back | 100 in 1 BOTTLE | TABLET | 100 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62795-1007 | BHI BACK (AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, AND TOXICODENDRON PUBESCENS LEAF) TABLET [MEDINATURA INC] | 4 | Current NDC, Legacy NDC, 3 package rows | 20230524_aa622a5b-16de-4098-9c3f-d7569f7d2c2f.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62795-1007-2 | EA - Each | 62795-1007 | 7ad988ac-fb01-4488-9a29-547d53401d85 | 1 | 2015-10-02 |
| 62795-1007-3 | EA - Each | 62795-1007 | 79905c80-e9d9-4b36-a686-e5967960a305 | 1 | 2023-06-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AMMONIUM CHLORIDE | ACTIVE INGREDIENT | 01Q9PC255D | 1 | |
| CITRULLUS COLOCYNTHIS FRUIT PULP | ACTIVE INGREDIENT | 23H32AOH17 | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| MATRICARIA RECUTITA | ACTIVE INGREDIENT | G0R4UBI2ZZ | 1 | |
| PSEUDOGNAPHALIUM OBTUSIFOLIUM | ACTIVE INGREDIENT | 36XQ854NWW | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| AMMONIUM CATION | ACTIVE MOIETY | 54S68520I4 | 1 | |
| CITRULLUS COLOCYNTHIS FRUIT PULP | ACTIVE MOIETY | 23H32AOH17 | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| MATRICARIA RECUTITA | ACTIVE MOIETY | G0R4UBI2ZZ | 1 | |
| PSEUDOGNAPHALIUM OBTUSIFOLIUM | ACTIVE MOIETY | 36XQ854NWW | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62795-1007 | 62795-1007-3, 62795-1007-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| AMMONIUM CHLORIDE | 01Q9PC255D | ACTIM |
| MATRICARIA RECUTITA | G0R4UBI2ZZ | ACTIB |
| CITRULLUS COLOCYNTHIS FRUIT PULP | 23H32AOH17 | ACTIB |
| GELSEMIUM SEMPERVIRENS ROOT | 639KR60Q1Q | ACTIB |
| PSEUDOGNAPHALIUM OBTUSIFOLIUM | 36XQ854NWW | ACTIB |
| TOXICODENDRON PUBESCENS LEAF | 6IO182RP7A | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BHI Back | AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, AND TOXICODENDRON PUBESCENS LEAF | MediNatura Inc | aa622a5b-16de-4098-9c3f-d7569f7d2c2f | 2023-05-23 | Warnings | 62795-1007-2 62795-1007-3 62795-1007 62795100702 62795100703 af2b8787-5aee-4b15-afe6-65f1beaa0201 aa622a5b-16de-4098-9c3f-d7569f7d2c2f |
Adverse event summaries are temporarily unavailable. Other product information remains available.